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Binding site plasticity in viral ppxY 
Late domain recognition by the 
third WW domain of human NEDD4
Manuel iglesias-Bexiga1,7, Andrés palencia1,8, Carles corbi-Verge2, Pau Martin-Malpartida3, 
francisco J. Blanco4,5, Maria J. Macias3,6, Eva S. cobos1 & irene Luque1*
The recognition of PPxY viral Late domains by the third WW domain of the HECT-E3 ubiquitin ligase 
NEDD4 (hNEDD4-WW3) is essential for the completion of the budding process of numerous enveloped 
viruses, including Ebola, Marburg, HTLV1 or Rabies. hNEDD4-WW3 has been validated as a promising 
target for the development of novel host-oriented broad spectrum antivirals. Nonetheless, finding 
inhibitors with good properties as therapeutic agents remains a challenge since the key determinants 
of binding affinity and specificity are still poorly understood. We present here a detailed structural 
and thermodynamic study of the interactions of hNEDD4-WW3 with viral Late domains combining 
isothermal titration calorimetry, NMR structural determination and molecular dynamics simulations. 
Structural and energetic differences in Late domain recognition reveal a highly plastic hNEDD4-WW3 
binding site that can accommodate ppxY-containing ligands with varying orientations. these 
orientations are mostly determined by specific conformations adopted by residues I859 and T866. 
Our results suggest a conformational selection mechanism, extensive to other WW domains, and 
highlight the functional relevance of hNEDD4-WW3 domain conformational flexibility at the binding 
interface, which emerges as a key element to consider in the search for potent and selective inhibitors of 
therapeutic interest.
Human NEDD4 (hNEDD4) is a HECT type E3 ubiquitin ligase widely expressed and evolutionarily conserved 
in eukaryotes. hNEDD4 is one of the nine members of the NEDD family of E3 ubiquitin ligases, characterized by 
a conserved modular architecture consisting of an N-Terminal C2 Ca2+-regulated lipid binding domain, 2 to 4 
WW protein interaction domains in charge of substrate recognition through the interaction with PY containing 
sequences, and a highly conserved HECT catalytic domain1,2. hNEDD4 functions within the ubiquitin proteas-
ome system regulating trafficking and stability of signaling proteins implicated in many cellular processes, includ-
ing sodium homeostasis, T-cell regulation, control of neuronal function and cellular growth and proliferation1,2. 
Its abnormal activity has been associated to the development of cancer and hypertension3,4. hNEDD4 is also 
implicated in the progression of viral infection, playing an essential role in the budding process of encapsulated 
viruses, including filoviruses (Ebola, Marburg), rhabdoviruses (Lassa) or arenaviruses (Rabies)5,6, through its 
interactions with viral Late domains.
Viral L- or Late domains are short and conserved sequences found in the gag polyproteins of retroviruses and 
in the matrix proteins of filoviruses (VP40), arenaviruses (Z) and rhabdoviruses (M) in different numbers and 
combinations. Three types of Late domains have been described, characterized by different core motifs (PPxY, 
P(T/S)AP and LYP(x)nL), that are interchangeable between divergent viruses and active in a context-independent 
manner7. Viral Late domains function by recruiting the cellular membrane scission machinery (i.e. the ESCRT 
pathway) to the viral site of budding at the plasma membrane through the establishment of direct interactions 
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with several host factors: P(T/S)AP Late domains interact with the UEV domain of Tsg101, LYP(x)nL Late 
domains with the V domain of the adaptor protein Alix and PPxY Late domains bind to the third WW domain of 
hNEDD45,8,9. Mutation or deletion of viral Late domains results in the accumulation of immature viral particles 
that remain attached to the cell, halting the infection6,7, and small molecule inhibitors targeting Late domain inter-
actions with their cellular targets can efficiently block egress of a number of viruses10,11. Thus, hNEDD4-WW3 
constitutes an attractive target for the development of novel, host-oriented, broad-spectrum antivirals with low 
susceptibility to the development of drug resistance.
WW domains are small protein modules (30–40 amino acids) that fold into a stable three-stranded antipar-
allel β-sheet12,13. WW domains are named after two conserved tryptophan residues spaced 20 to 22 residues 
apart within the sequence: the first tryptophan lies on one side of the β-sheet conforming a hydrophobic core 
important for domain stability; the second tryptophan is located at one hydrophobic pocket at the binding site, 
the xP pocket, dedicated to poly-proline recognition and common to other proline interaction modules (SH3 and 
UEV domains). WW domains have been classified according to the motifs they recognize. A second pocket in 
the binding site is responsible for binding specificity within WW domains subfamilies, and, in the case of type-1 
WW domains, such as hNEDD4-WW3, it is dedicated to the recognition of the Tyr residue in the PPxY consen-
sus core-motif14,15. The search for high affinity and specificity ligands of WW domains with good properties as 
therapeutic agents and limited secondary effects is challenging due to the promiscuity and low affinity of their 
natural interactions, which, as in other polyproline recognition modules such as SH3 or UEV domains, involve 
shallow and relatively featureless interfaces. Thus, developing efficient inhibitors of hNEDD4-WW3/Late domain 
interactions with good potential as novel antivirals requires a profound understanding of the rules governing 
molecular recognition in these systems16–19, which, in spite of the wealth of structural and functional studies on 
WW domains, remains to be elucidated.
Here we present a detailed structural and thermodynamic study of the interactions between hNEDD4-WW3 
and a set of viral Late domains combining isothermal titration calorimetry, NMR structural determination 
and molecular dynamics simulations. We show that short Late domain sequences from different viruses bind 
with low to moderate binding affinity and good selectivity to hNEDD4-WW3, although large differences (up to 
20 kJ·mol−1) in the enthalpic and entropic contributions to the binding Gibbs energy are found for the different 
ligands, reflecting heterogeneity in the underlying balance of forces driving recognition. The NMR structures 
of the Ebola and HTLV1 complexes, representative of the two extreme thermodynamic behaviors, confirm this 
heterogeneity. They also reveal conformational differences at the binding site that modulate the size and shape of 
the xP and xY pockets, inducing changes in the interaction patterns and different orientations of the two ligands 
on the hNEDD4-WW3 surface. Molecular dynamics simulations confirm a high conformational variability at the 
binding site of apo-NEDD4-WW3 that is drastically reduced upon binding of the different ligands, each stabiliz-
ing different binding site geometries. This suggests a conformational selection mechanism, further sustained by 
the analysis of the structural database of WW complexes, highlighting the high plasticity of the hNEDD4-WW3 
binding site, which is determined mostly by residues I859 and T866. Together, our results highlight the functional 
relevance of the conformational plasticity of hNEDD4-WW3 that emerges as a key element to consider in the 
search for potent and selective inhibitors of therapeutic interest.
Results
Thermodynamic analysis of the binding of Late domain peptides to hNEDD4-WW3. The bind-
ing energetics of hNEDD4-WW3 to a set of five peptide ligands corresponding to the Late domain sequences of 
different viruses (Supplementary Table S1) were directly measured by Isothermal Titration Calorimetry (ITC) 
(Fig. 1). The p53bp2 human peptide, previously described to interact with moderate to high binding affinity with 
several WW domains20,21, and the isolated PPPY motif were included in the analysis as a reference. To probe the 
level of selectivity encoded within these Late domain sequences, binding of the different ligands to the class I 
WW1 and WW2 domains from YAP was also studied. The results of the thermodynamic analysis are summarized 
in Table 1.
Late domain peptides selected to contain the PPxY motif centered in the sequence bind to hNEDD4-WW3 
with dissociation constants close to 50 μM, with the exception of the Ebola ligand that shows a lower binding 
affinity (Kd = 147 μM). Placing the PPxY motif at the C-terminal end of the ligands leads to a marked reduction 
in binding affinity: the dissociation constant for the Human T-Cell Leukaemia Virus-1 Late domain (HTLV1ter) 
drops to values similar to those measured for the isolated PPPY motif (Kd = 201 μM) and no binding could be 
detected for the Ebolater ligand, neither by ITC nor by fluorescence spectroscopy. In terms of binding selectivity, 
we find that, while the cellular peptide p53bp2 and the isolated PPPY motif do not distinguish between the three 
WW domains, all Late domain peptides bind preferentially to their cellular target, hNEDD4-WW3. Moreover, 
the interaction of these ligands with the YAP WW domains was, in some instances, non detectable and, at best, 
similar to the non-specific interaction of the isolated PPPY motif, with dissociation constants ranging between 
200 and 800 μM. Together, these results confirm that the isolated Late domain sequences maintain the ability 
to interact with hNEDD4-WW3 and suggest that the determinants of binding affinity and specificity for Late 
domain recognition are partially encoded in the residues flanking the PPxY core motif in the viral proteins.
Binding of all ligands to hNEDD4-WW3 show the thermodynamic profile previously described for polypro-
line recognition by other WW and SH3 domains: i.e. the interaction is driven by markedly favorable binding 
enthalpies partially opposed by unfavorable entropic contributions. The binding enthalpy of the isolated PPPY 
motif represents between 55% to 75% of the binding enthalpy of the different ligands (Table 1 and Fig. 1), indi-
cating that, even though the establishment of additional interactions with flanking residues in the peptide ligands 
might modulate the magnitude of the enthalpic contributions, the exothermic character of the interaction is 
inherent to the recognition of the proline-rich PPxY motif. The Ebola ligand presents an enthalpy change of 
−50.7 kJ·mol−1, very similar to the nonspecific high affinity ligand p53bp2 and only slightly higher than the 
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isolated PPPY motif. Nonetheless, all other Late domain peptides are characterized by more exothermic binding 
enthalpies, close to −70 kJ·mol−1. Even though the impact of this large enthalpic difference (20 kJ·mol−1) on the 
binding affinity is mitigated by enthalpy/entropy compensation effects, it reflects a modulation in the balance of 
forces driving the interaction for the two groups of ligands (p53bp2, PPPY and Ebola peptides vs HTLV1, Rabies 
and Marburg sequences), suggesting differences in the way they interact with the hNEDD4-WW3 domain.
NMR structural characterization of hNEDD4-WW3/Late domain complexes. The Ebola and 
HTLV1 Late domain peptides were selected as examples of each group of ligands and 1H-15N-HSQC NMR titra-
tion experiments were performed to evaluate possible differences in hNEDD4-WW3 recognition. Addition of 
unlabeled HTLV1 and Ebola peptides to the previously assigned 15N-labeled NEDD4-WW3 domain resulted in 
significant chemical shift perturbations (CSP) of the backbone amide signals throughout the domain, eliciting a 
very similar pattern for both complexes (Fig. 2a). The largest perturbations were observed for residues defining 
the xP and xY canonical binding pockets22: F857, F858 and I859 (β2 strand); H861 and K864 (β2/β3 loop), T865, 
T866 and T867 (β3 strand); and W868 and E869 (Fig. 2b). Additionally, binding of HTLV1 and Ebola affects res-
idues E847, V848 and R849 (β1 strand) and R855 (β1/β2 loop) outside the xP and xY pockets, in agreement with 
previous reports on other WW complexes23–28. In spite of the similarity between the two complexes, the indole 
group of W868 (Hε1) at the xP pocket, previously used to monitor binding in several WW domains13,21, responds 
differently to the presence of each ligand, experiencing a large shift in the HTLV1 complex (CSP ~ 2 ppm) that is 
much reduced for Ebola (CSP < 0.5 ppm).
To further investigate these differences, the structures of the HTLV1 and Ebola complexes were solved by 
NMR. A total of 50 (HTLV1) and 52 (Ebola) manually assigned intermolecular NOEs were used for the calcu-
lation of the complex structures, the most relevant of which are summarized in Supplementary Table S2. Most 
NOEs with the WW domain were concentrated in the PPxY core motif region, which adopts a PPII conformation 
and shows the typical binding mode described for other WW complex structures23,27–29. For both complexes, the 
Figure 1. Binding energetics of Late domain peptides to hNEDD4-WW3. (a) Calorimetric titrations of peptide 
ligands into the hNEDD4-WW3 domain. Upper panels show the heat effects associated with the injection of 
each ligand into the calorimetric cell containing the hNEDD4-WW3 domain (1) and the dilution experiment 
of each ligand into the corresponding buffer under the same conditions and identical injection profile (2). The 
dilution curve has been displaced in the y-axis for representation purposes. Lower panels show the binding 
isotherm (open symbols) together with the best fit (continuous lines) to an appropriate binding model (see 
Methods for details). (b) Thermodynamic dissection of the binding energetics. Shown is the binding Gibbs 
energy (black bars) as well as the enthalpic (green bars) and entropic (blue bars) contributions. All parameters 
were determined at 25 °C in 20 mM sodium phosphate pH 7.0.
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first two prolines in the motif (P−3′ and P−2′) are involved in stacking interactions at the xP pocket of the domain 
(P−3’ shows several NOEs to the W868 aromatic ring and P−2′ interacts with the F857 side chain). Also, the tyros-
ine residue at the core motif (Y0′) shows NOEs to the methyl groups of T866, to the γ protons of I859 and K864, 
and to the α and ε protons of H861 in the two structures.
No NOE signals could be detected for the first three residues at the N-terminus of the HTLV1 and Ebola lig-
ands (S−8D−7P−6 and I−8L−7P−6 respectively), suggesting lack of interaction with the hNEDD4-WW3 domain. To 
evaluate any possible influence of these residues, we calculated the structures of the full-length Ebola and HLTV1 
complexes and their shortened versions (HLTV1: Q−5IP−3P−2PY0VEP3 and Ebola: T−5AP−3P−2EY0MEA3), which 
correspond to the part of the peptides with inter-molecular NOEs. As illustrated in Supplementary Fig. S1a, show-
ing the superposition of the 20 lowest energy NMR ensembles obtained with the short and full-length peptides, 
the structural models are fully equivalent within experimental resolution. The main difference is observed at the 
first three N-terminal residues, which appear unstructured and randomly distributed for both HTLV1 and Ebola 
complexes. Moreover, the presence or absence of these three residues does not alter the side chain conformation 
of the well-defined regions of the ligand (Supplementary Fig. S1b), confirming that the complexes with the short 
peptides capture all essential elements of Ebola and HTLV1 Late domain interaction with hNEDD4-WW3.
This observation is in agreement with previous studies on NEDD4-WW3 complexes indicating that N ter-
minal residues beyond position −5 do not influence NEDD4-WW3 recognition. For instance, Kanelis et al.25 
found that elongating the T−5GL−3P−2SY0DEA3LH (Kd = 3.1 μM) peptide two positions N-terminal did not 
have any effect on binding affinity. Similarly, the R−6P−7 residues of the high affinity (Kd = 3 μM) ARRDC3 
ligand (RPE−5AP−3P−2SY0AEVVT) were also not observed in the crystal structure of the complex (4N7H), 
probably because these residues populated several conformations28. All these observations led us to consider 
that NMR-based models calculated with the short versions of the Ebola and HTLV1 peptides recapitulate the 
hNEDD4-WW3 Late domain binding properties to the Ebola and HTLV1 peptides and these complexes were 











20 4.1 ± 0.2 −45.6 ± 0.3
−1.59 ± 0.0125 5.3 ± 0.5 −53.2 ± 0.7
30 9.1 ± 0.3 −61.1 ± 0.6
YAP-WW1
20 1.1 ± 0.5 −54.8 ± 0.2
−1,16 ± 0.0625 1.8 ± 0.1 −61.1 ± 0.3
30 3.0 ± 0.1 −66.4 ± 0.5
YAP-WW2
20 — —




NEDD4-WW3 25 61 ± 1 −68.2 ± 0.6
—YAP-WW1 25 #308 ± 4 —
YAP-WW2 25 #260 ± 40 —
HTLV1ter
P−3′P−2′PY0′VEPTAP
NEDD4-WW3 25 178 ± 3 −74.0 ± 0.8
—YAP-WW1 25 n. b. —
YAP-WW2 25 n. b. —
Ebola
ILPTAP−3′P−2′EY0′MEA
NEDD4-WW3 25 147 ± 4 −50.7 ± 0.7
—YAP-WW1 25 #750 ± 10 —
YAP-WW2 25 #560 ± 30 —
Ebolater
ILPTAP−3P−2′EY0′
NEDD4-WW3 25 n. b. —
—YAP-WW1 25 n. b. —
YAP-WW2 25 n. b. —
Marburg
MQYLNP−3′P−2′PY0′ADH
NEDD4-WW3 25 51 ± 1 −73.2 ± 0.7
—YAP-WW1 25 #67 ± 4 —
YAP-WW2 25 #17 ± 1 —
Rabies
DLWLPP−3′P−2′EY0′VPL
NEDD4-WW3 25 51 ± 1 −65.8 ± 0.8
—YAP-WW1 25 181 ± 5 −63.7 ± 0.9
YAP-WW2 25 n. b. —
PPPY
P−3′P−2′PY0′
NEDD4-WW3 25 210 ± 15 *−38 ± 1
—YAP-WW1 25 320 ± 30 *−39 ± 3
YAP-WW2 25 n. b. —
Table 1. Binding energetics of peptide ligands to the hNEDD4-WW3, hYAP-WW1 and hYAP-WW2 
domains. #Dissociation constants determined by titration experiments followed by fluorescence spectroscopy. 
*Thermodynamic parameters obtained by ITC competitive experiments using the p53bp2 ligand. n. b.: no 
binding.
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The twenty lowest energy structures after water refinement for each complex (Supplementary Fig. S2) show 
an average Root Mean Square Deviation (RMSD) for all backbone heavy atoms of 0.60 Å for the HTLV1 com-
plex and 0.83 Å for the Ebola complex. The statistics of the calculation are summarized in Table 2. Most residues 
in both complexes were found in favored or allowed regions of the Ramachandran plot. In both structures the 
hNEDD4-WW3 domain presents the right hand twisted anti-parallel β sheet fold characteristic of WW domains, 
showing three well defined β strands comprising residues E847-A851 (β1), P856-D860 (β2), and T865-T867 (β3) 
(Fig. 3a). Overall, the backbone structure of the WW domain does not differ between the HTLV1 and Ebola com-
plexes and is also very similar to other hNEDD4-WW3 structures (Supplementary Fig. S3).
Comparison with the NMR structure of the ENaC complex (2M3023) and the crystal structure of the ARRDC3 
complex (4N7H28) results in average RMSD values for the backbone heavy atoms that range between 1.0 and 
1.2 Å. Comparison with the NMR (5AHT30) and crystal (4N7F28) structures of the free domain renders similar 
results, although RMSD values up to 1.8 Å are locally observed for residues A851, P852, N853 and G854 at the 
β1-β2 loop.
The side chains that constitute the hydrophobic buckle stabilizing the WW domain structure (W846, F858 
and P871) and most residues implicated in ligand recognition (F857, H861, K864, and W868) also show very 
similar conformations in the Ebola and HTLV1 complexes (Fig. 3a). Nonetheless, residues I859 and T866, placed 
at the center of the binding site and delimiting the xP and xY pockets, are found in different conformers in each 
complex structure (χ1I859: −46° and χ1T866: +41° for HTLV1 and χ1I859: +43° and χ1T866: −18° for Ebola). 
These conformational differences, reminiscent of those observed between the crystal structure of the ARRDC3/
NEDD4-WW3 complex and the free domain28, modulate the shape and size of the xP and xY pockets, inducing 
changes in the pattern of binding site interactions and a different orientation of the HTLV1 and Ebola ligands on 
the surface of the WW domain (Fig. 3b).
As illustrated in Fig. 3c, the HTLV1 rotamer combination results in a deeper xP pocket that allows a tight fit 
of the P−2′ and P−3′ side chains: a close contact between the HTLV1 P−3′ side chain and W868 is confirmed by 
the large chemical shift displacement of its indole amide upon ligand binding (Fig. 2); also, a direct hydrogen 
bond is formed between the T866 side chain and the carbonyl oxygen of P−3′ (Fig. 3d). These interactions are not 
observed in the Ebola complex, in which the conformation adopted by T866 reduces the size of the xP pocket, 
hindering the docking of P−2′ and P−3′, and placing the hydroxyl oxygen at distances incompatible with the for-
mation of hydrogen bonding interactions with the carbonyl oxygen of P−2′ or P−3′. In compensation, the I859/
T866 side chain arrangement in the Ebola structure results in a well-defined xY pocket that allows the tyrosine 
Figure 2. NMR titration of Ebola and HLTV1 Late domains onto the hNEDD4-WW3 domain. (a) 
Superposition of four 1H-15N-HSQC spectra of hNEDD4-WW3 domain at different protein/ligand ratios. 
Upper panel shows spectra obtained at 1:0.0 (blue), 1:0.5 (purple), 1:1.5 (pink) and 1:3.0 (orange) molar ratios 
for the HTLV1 complex. Lower panel shows spectra at 1:0.0 (blue), 1:1.0 (purple), 1:2.5 (pink) and 1:10.0 
(orange) molar ratios for the Ebola complex. The signal of the indole proton of W868, which shows a differential 
behavior in the two complexes, has been highlighted in a red box. (b) Average Chemical Shift Perturbations 
(CSPs) calculated at the last titration point for each residue in the 1H-15N-HSQC spectra of NEDD4-WW3 
domain in the presence of 1:3 excess HTLV1 peptide (upper panel) and 1:10 excess Ebola peptide (lower panel). 
The experimental error for the spectral resolution is estimated to be ±0.03 ppm (see Methods for details).
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side chain in the PPxY motif (Y0′) to be deeply buried. A wider and shallower xY pocket is observed in the HTLV1 
complex, characterized by a higher exposure of the Y0′ side chain, associated in part to the change in conforma-
tion of the H861 side chain, which is directed outwards in this structure (Fig. 3c and Supplementary Fig. S3). This 
is in agreement with the differences in the CSP values (1.2 ppm in Ebola vs 0.8 ppm in HTLV) registered for the 
backbone amide of T865 located at the bottom of the xY pocket (Fig. 2a).
Additional differences are also found at the N- and C-terminal regions of the ligands. As is common in viral 
Late-domains sequences, which frequently carry negatively charged residues one or two positions C-terminal 
from the PPxY motif5, both HTLV1 and Ebola ligands have a glutamate residue at position +2 that is implicated 
in electrostatic interactions with R849 at the β1 strand. Nonetheless, the assigned signals defining this interaction 
are also slightly different in the two complexes: the two NOEs observed between the ε protons of R849 and the 
γ1 and γ2 protons of E2’ in the HTLV1 ligand shift to the γ1 and β2 protons in the Ebola complex, resulting in a 
different conformation for the E2′ side chain (Fig. 3c). At the N-terminal region, weak NOEs signals are observed 
between residues at positions 5′ and 4′ in the ligand (HTLV1 Q−5′and I−4′ and Ebola T−5′ and A−4′) and the side 
chain of W868 at the end of the β3 strand (Supplementary Table S2). Nonetheless, the carbonyl oxygen of the 
residue at position −5′ forms an intermolecular hydrogen bond with different partners in each complex: HTLV1 
Q−5′ interacts with the side chain of W868, establishing a hydrogen bond very similar to that found in the x-ray 
structure of the ARRDC3 complex28, while Ebola T−5′ is removed from the W868 side chain and found at hydro-
gen bond distance of the carboxyamide of N853 (Fig. 3d). This interaction brings the ligand closer to the β1-β2 
loop that adopts a slightly different conformation in the two complex structures (Fig. 3a).
HTLV1 PDB:2KPZ Ebola PDB: 2KQ0
Number of structural restraints
All restraints 679 625
Sequential (|i − j| = 1) 259 236
Medium range (1 < |i − j| ≤ 4) 90 72
Long range (|i − j| > 4) 264 209
Intermolecular 50 52
Ambiguous restraints 0 0
Dihedral angles 50 40
Hydrogen bonds 16 16
Average restraints per residue (43 residues) 15.7 14.5
RMSD from the restraintsa <SA>b
All NOE distance restraints (Å): 10.1·10−3 ± 3·10−4 4.4·10−3 ± 4·10−4
Bonds (Å) 8.3·10−3 ± 2·10−4 4.2·10−3 ± 2·10−4
Dihedral angles (°) 0.83 ± 0.03 0.59 ± 0.02
Average atomic RMSD from the minimum energy structure (Å), (whole complex)
Backbone N, Cα and CO atoms, (secondary structure only) 0.43 0.59
Backbone N, Cα and CO atoms all residues 1.15 1.56
All Heavy atoms, all residues 2.48 2.66
Average atomic RMSD from the complex (Å), (domain only in the complex)
Backbone N, Cα and CO atoms, all residues 1.01 1.44
All Heavy atoms, all residues 2.47 2.54
Average atomic RMSD from the complex (Å), (peptide only on the complex)
Backbone N, Cα and CO atoms, all residues 1.51 1.90
All Heavy atoms, all residues 2.65 3.24
Energetic quality (kcal mol−1)
Total energyc −1260 ± 50 −1540 ± 30
Electrostatic −1630 ± 50 −1750 ± 40
van der Waals −120 ± 10 −140 ± 10
Bonds 51 ± 2 13 ± 1
Angles 140 ± 10 72 ± 6
Ramachandran map analysisd (%)
Residues in most favoured regions 91.2 84.7
Residues in additionally allowed regions 7.3 14.1
Residues in generously allowed regions 1.5 0.9
Residues in disallowed regions 0 0.3
Table 2. Structural statistics for the NEDD4-WW3/Late domain complexes. aAfter water refinement no 
distance restraint was violated by more than 0.3 Å. b<SA> refers to the ensemble of the twenty structures 
with lowest energy. cThe total energy is the Lennard-Jones van der Waals energy (EL-J) calculated using 
CHARMMPARMALLH6 parameters54. EL-J was not included in the target function during structure calculation. 
dThe Ramachandran map was calculated using PROCHECK55.
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In summary, the structural analysis confirms small conformational differences at the binding site region and 
a different pattern of binding site interactions between the two complexes that correlate well with the thermody-
namic results. In this way, a higher number of intermolecular interactions are established in the HTLV1 complex 
Figure 3. Structural comparison of the Ebola and HTLV1 complexes with hNEDD4-WW3. (a) Structural 
superposition of the hNEDD4-WW3 domain structure (light brown cartoons) from the Ebola and HTLV1 
complexes. Shown are the lowest energy models in the NMR ensembles. The side chains of the WW domain 
residues involved in binding are shown as orange (HTLV1) and blue (Ebola) sticks. (b) Orientation of the Ebola 
(blue) and HTLV1 (orange) ligands on the hNEDD4-WW3 binding site. Residues I859 and T866, determining 
the size of the xP and xY pockets in these complexes and defining ligand orientation are shown as blue (Ebola) 
and yellow (HTLV) sticks. (c) Detail of the interactions established by the HTLV1 (upper panels) and Ebola 
(lower panels) ligands at the different regions on the hNEDD4-WW3 binding site. (d) Intermolecular hydrogen 
bonds established between the HTLV1 (left panel) and the Ebola (right panel) Late domain peptides and the 
hNEDD4-WW3 domain. The WW domain is shown in a light blue cartoon representation. The most relevant 
side chains for ligand recognition are shown in light blue sticks. Ligand atoms are shown as orange (HTLV1) 
and dark blue (Ebola) sticks. Hydrogen bonds are depicted as discontinuous black lines.
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in comparison with the Ebola structure (Fig. 3d and Supplementary Table S3), in agreement with the more exo-
thermic binding enthalpy of HTLV1 (ΔΔHHTLV-Ebola = −20 kJ/mol−1). By extrapolation, the sign and magnitude 
of the binding enthalpies of the Rabies and Marburg Late domain suggest an HTLV1-like binding mode.
Conformational properties of hNEDD4-WW3/Late domain complexes studied by Molecular 
Dynamics simulations. In order to further investigate the conformational variability observed for the 
hNEDD4-WW3 binding site, we calculated 40 ns molecular dynamics trajectories using our Ebola (2KP0) 
and HTLV1 (2KPZ) complex structures and the crystal structure of the free NEDD4-WW3 domain (4N7F) 
as starting points. For comparison, equivalent simulations were performed for the NMR structure of the apo 
mNEDD4-WW3 domain (1WR7), of very similar sequence and longer N- and C-termini (Supplementary 
Fig. S4a). The backbone root-mean-square deviation (RMSD) for the WW domain rapidly reaches a stable pla-
teau at about 1–2 Å without abrupt transitions in the energy profile, indicating that in all cases the WW domain is 
stable throughout the simulations. A similar situation was found for the ligand atoms (Supplementary Fig. S4b).
Analysis of the average mass-weighted fluctuation per residue (Supplementary Fig. S4c) reveals that the β1-β2 
and β2-β3 loop regions undergo large motions (2–2.4 Å) in the free domain simulations that are reduced upon 
ligand binding. Nonetheless, while the stabilization of the β1-β2 loop is very similar for both complexes, the β2-β3 
loop remains more flexible in the HTLV1 complex. This structure presents a binding site geometry and ligand 
configuration very similar to that of ENaC/NEDD4-WW3 complex (2M30) (Supplementary Fig. S5a), for which 
NMR dynamic studies showed that in the bound state the β2-β3 loop exists in equilibrium between two differ-
ent backbone conformations23. In contrast, the Ebola ligand seems to be more efficient stabilizing this region, 
possibly due to the better packing of Y0′ side chain at the xY pocket that allows more extensive contacts between 
C-terminal region of the ligand and the β2–β3 loop (Supplementary Fig. S5b).
The most relevant intermolecular interactions between the ligands and the hNEDD4-WW3 domain remain 
stable throughout de MD trajectories, providing a description of the two complexes consistent with the NMR 
structures. The average ligand/domain contact distances (Supplementary Fig. S6a) closely reproduce the exper-
imental pattern of intermolecular NOEs, capturing the P−3′/W868 and P−2′/F857 contacts, the different packing 
of Y0′ at the xY pocket (I859, H861, K864 and T866), with 1–1.5 Å smaller average contact distances for the Ebola 
complex, as well as other interactions implicating the N- and C- terminal regions of the ligands (W868 with resi-
dues at position −4′ and −5′ and R849 with E2′). The hydrogen bond pattern also reflects the differences between 
the two complexes (Supplementary Fig. S6b).
Globally, the simulations reveal a high level of binding site plasticity for the free NEDD4-WW3 domain that 
is drastically reduced upon binding of the two ligands. A cluster analysis of the two MD trajectories obtained for 
the free NEDD4-WW3 domain (4N7H and 1WR7) consistently produced four highly populated clusters, with 
occurrences ranging between 11% and 36% of the simulation time that show a considerable variability in the size 
and shape of the xP and xY pockets (Fig. 4a–d).
Binding of the HTLV1 and Ebola ligands results in narrower conformational distributions. Three clusters with 
occurrences >5% were identified for each complex, characterized by very similar backbone conformation for the 
WW domain (RMSD = 1.3 Å for the HTLV1 and 0.9 Å for the Ebola complex) but larger deviations for the ligand 
atoms (RMSD = 3.8 Å for HTLV1 and 3.5 Å for Ebola). The HTLV1 complex is characterized by a clearly predom-
inant cluster that accounts for 87% of the simulation time while the other two clusters are only sporadically visited 
(occurrences of 6% and 5%). The Ebola complex retains a higher level of conformational flexibility at the binding 
site, showing two highly populated clusters, with 58% and 32% occurrence (Fig. 5).
Analysis of the conformations adopted by the Ile859 and Thr866 side chains in the MD trajectories (Fig. 5) 
parallels this behavior, highlighting the binding site plasticity of the apo domain and the conformational differ-
ences between the two complexes. The I859/T866 pair shows high side chain mobility in free domain, frequently 
fluctuating between different combinations of dihedrals: Ile859 alternates mostly between the two gauche rotam-
ers while T866 shows more variability, visiting also the trans conformer. The presence of the two ligands induces 
a marked reduction in the mobility of these two residues, with each ligand preferentially populating a specific set 
of conformations: a clearly predominant combination of dihedrals, accounting for 85% of the simulation time, 
is found in the HTLV1 trajectory, in contrast with the Ebola complex, that shows a higher conformational varia-
bility for the Thr866 side chain. Interestingly, none of the χ1 combinations found for one complex are observed 
in the other, except for the most frequent conformation for the Ebola complex (cluster 2) that is only transiently 
observed for HTLV1 (5% occupancy). The predominant conformation for HTLV1 is not significantly populated 
in the Ebola trajectory.
The MD conformational behavior is also in agreement with the rotamer variability found for the Ile859/
Thr866 pair in the NMR ensembles of the Ebola and HTLV1 complexes: HTLV1 presents a single and well 
defined conformation (χ1I859 = −46º ± 2º and χ1T866 = 42º ± 5º) in all 20 models, while Ebola shows a higher 
conformational variability, so that the 20 lowest energy structures in the Ebola ensemble are grouped in three 
sets of conformations, with frequencies of 65% (χ1I859 = 48º ± 6º / χ1T866 = −179º ± 6º), 20% (χ1I859 = 52º ± 3º / 
χ1T866 = −55º ± 5º) and 15% (χ1I859 = 47º ± 2º / χ1T866 = 48º ± 5º), in good correspondence with the MD clusters 
(see also Fig. 6).
Thus, the molecular dynamics study further sustains the idea of a differential recognition of the two ligands 
by the NEDD4-WW3 domain, revealing a higher level of conformational diversity for the Ebola complex with 
respect to HTVL1, in agreement with the thermodynamic results, showing a smaller entropic penalty for the 
binding of the Ebola ligand (−TΔΔSEbola-HTLV1 = 24 kJ/mol−1).
Analysis of the structural database for type I WW domain complexes. In order to assess whether 
one of the two orientations observed for the Ebola and HTLV1 ligands represents a “canonical” or most common 
9Scientific RepoRtS |         (2019) 9:15076  | https://doi.org/10.1038/s41598-019-50701-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 4. Variability in hNEDD4-WW3 binding site geometry. Uppers panels (a–d) show the surface depiction 
of the representative structures from the four most populated clusters in the apo-NEDD4-WW3 domain 
simulation. Lower panels show the surface representation of the hNEDD4-WW3 domain from the crystal 
structure of the ARRDC3 complex (4N7H)28 (e), the lowest energy NMR models for the HTLV1 and Ebola 
complexes (this work 2KPZ and 2KQ0) (f,g) and the crystal structure of the apo NEDD4-WW3 domain (4N7F) 
(h). Residues in the xY pockets are colored in yellow, the xP pocket in light blue. Shown are the estimated sizes 
for the two pockets calculated with FPocket68.
Figure 5. Molecular dynamics study of hNEDD4-WW3 conformational plasticity. Modulation of the 
hNEDD4-WW3 conformational distribution upon ligand binding. The central panel shows the evolution 
throughout the trajectory of the I859 (black dots) and T866 (red dots) side chain dihedrals for the apo 
domain and the Ebola and HTLV1 complexes. Right and left panels show representative structures of the 
most populated clusters for the Ebola (blue) and HTLV1 (orange) simulations. Also shown are the respective 
frequencies of occurrence and the side chain dihedrals for the I859 and T866 residues.
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binding mode for PPxY peptides, the 21 high-resolution structures currently available for class-I WW complexes, 
covering a range of two orders of magnitude in binding affinity, were examined (see Supplementary Table S4). 
Even though the structures of these closely related WW domains are very similar (RMSD values with respect to 
the free domain (4N7F) are below 1.5 Å in all cases), a significant dispersion in the orientation of the ligands was 
found, paralleling the situation described for the Ebola and HTLV1 complexes. The complex structures could 
be classified in three different groups according to the disposition of the ligand at the binding site: (I) a set of 7 
structures resembling HTLV1; (II) a set of 6 structures with a ligand orientation similar to the Ebola complex and, 
(III) a larger set of 11 structures showing an intermediate orientation, resembling the HTLV1 structure at the xP 
pocket and showing xY pockets similar to the Ebola complex (Fig. 6a).
The combinations of Ile859 and Thr866 dihedrals found in the high resolution structures (Fig. 6b), reproduce 
those of the most populated clusters identified in the molecular dynamics trajectories of the Ebola and HTLV 
Figure 6. Variability in ligand binding orientation for type I WW domains. (a) Cartoon representation of the 
hNEDD4-WW3 domain (light gray). The Ebola and HTLV1 ligands are shown as blue and orange ribbons, 
with the Y0 and P−2, P−3′ side chains shown as sticks. The PPxY core motif regions of the different ligands 
classified in each category are shown as ribbons. (b) Side chain dihedral angles for Ile858 and Thr866 in type I 
WW domains complexes. Open circles represent the side chain conformations observed in the high-resolution 
structures showing HTLV1-like (orange), Ebola-like (blue) or mixed (green) orientations. Following the same 
color code, full circles show the conformations adopted in the 20 lowest energy models from the Ebola and 
HTLV1 NMR ensembles, and open squares the most populated clusters identified in the molecular dynamics 
trajectories. Numbers indicate frequencies of occurrence. (c) Dissociation constants for the WW complexes in 
the structural database (see Supplementary Table S3) color coded by type of orientation: HTLV1-like (orange), 
Ebola-like (blue) and Mixed (green). (d) Side chain dihedral angles for Ile859 and Thr866 in type I WW 
domains complexes color coded according to binding affinity: Kd < 10 μM (black), 10 μM < Kd < 100 μM (red), 
and Kd > 100 μM (green).
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ligands and the conformations observed in the NMR structural ensembles. In agreement with the simulations, 
the HTLV1-like conformation is restricted to a narrow interval of Thr866-χ1 values, around 50°, in combination 
with two intervals of Ile/Val859-χ1 values centered at −50° and 180°. A significantly higher conformational 
variability is found for the Ebola-like complexes in which Thr866 can be found in two predominant conforma-
tions corresponding to the most populated clusters in the MD trajectory: one with Thr866-χ1 values similar 
to HTLV1 and a second interval centered around 180°. In both cases a significant dispersion in the values of 
Ile/Val859-χ1 is observed. The third class of ligands shows a conformational dispersion similar to that of the 
Ebola-type complexes.
These results suggest a high degree of plasticity in the recognition of PPxY containing ligands that can be 
accommodated with a wide range of orientations with respect to the WW domain binding site, determined by 
the set of rotamers adopted by Thr866 and Ile/Val859 side chains. No correlation between ligand orientation 
and binding affinity was observed, so that examples of high (Kd < 5 μM), medium (10 < Kd < 100 μM) and low 
(Kd > 100 μM) binding affinity are found in similar proportions for the three types of ligand orientations (Fig. 6b). 
Taken together, these results sustain the idea that binding site plasticity is not limited to low affinity complexes 
(which could be somewhat expected), but is rather a general feature of PPxY recognition by WW domains. Our 
analysis also indicates that high affinity ligand binding in type I WW domain is invariably associated to a very 
specific conformer for Ile859 (<χ1> = 67° ± 4° for all complexes with Kd < 5 μM), while a high variability is 
accepted for the Thr866 side chain.
Discussion
The thermodynamic study of the binding energetics of isolated viral Late domain sequences to hNEDD4-WW3, 
confirms that these peptide ligands, in the absence of other elements from the full-length protein, retain the abil-
ity to selectively recognize its host cellular target. All Late domain ligands present the thermodynamic signature 
previously described for other proline rich recognition modules, including SH331–33, UEV34,35 and other WW 
domains28,30,36, which, as previously discussed, cannot be fully rationalized considering exclusively the direct con-
tacts between the predominantly hydrophobic interacting surfaces32,37–39. For the hNEDD4-WW3 complexes, this 
is illustrated by the large discrepancies found between the measured binding enthalpies and the intrinsic binding 
enthalpies calculated from the analysis of the interacting surfaces16 (Supplementary Table S5), see Methods for 
details. These calculations, which typically predict binding enthalpies in different systems with an average error 
of 1.3 kJ· mol−1, render theoretical values of −21 and −18 kJ· mol−1 for the Ebola and HTLV1 complexes, which 
are 30 and 50 kJ· mol−1 smaller than the experimental enthalpies. Similar discrepancies are found for the ENaC 
and ARRDC3 complexes. Thus, the direct ligand/domain contacts can’t fully explain neither the absolute enthalpy 
values nor the large enthalpic differences between the ligands.
The origin of this characteristic thermodynamic behavior has been widely studied for SH3 domains and attrib-
uted to the interplay of several factors complementing the direct interfacial interactions: the establishment of 
extensive and partially conserved networks of water-mediated interactions at the binding interface detected in 
crystal structures37,38, the reorganization of the conformational distribution of peptide and domain upon bind-
ing31,33 and the modulation of the dynamic properties of the protein40,41. The extent to which these factors con-
tribute to the binding energetics in WW domains remains to be evaluated. High resolution crystal structures 
are scarce and, although some interfacial water molecules mediating the interaction between the domain and 
peptide ligands have been identified in a few WW complexes, the interaction networks are not as extensive as 
those observed in SH3 complexes39. In our particular case, no buried water molecules are found in the only 
crystal structure available of a hNEDD4-WW3 complex28, suggesting a marginal contribution of water-mediated 
interactions to the binding energetics of Late domain sequences. Conversely, the conformational contributions 
are likely to play a much more relevant role in WW binding energetics, since the small size of WW domains 
seems to impose a dual role in folding and function for many residues. Several folding and unfolding studies of 
WW domains have been performed in the past. The folding mechanisms of these domains seem to depend on 
their specific sequences, and due to their complexity, different experiments revealed different folding scenarios42. 
We have recently established that wild type NEDD4-WW3, NEDD4-WW4, FBP11-WW1, FBP11-WW2 and 
YAP65-WW1(L30K) are characterized by a downhill folding equilibrium that entails high flexibility and broad 
native state ensembles that can be continuously modulated by changes in conditions or mutations43,44.
hNEDD4-WW3 is one of the most paradigmatic examples of WW downhill folding, showing the lowest fold-
ing barriers and the highest level of flexibility amongst the studied WW domains44. This conformational variabil-
ity is captured by the molecular dynamics study of the hNEDD4-WW3 free domain that depicts a highly plastic 
binding site (Fig. 4a–d) and shows that binding of the Ebola and HTLV1 ligands selectively stabilize a small set of 
conformations, reducing the conformational variability within the complex distribution. This suggests a confor-
mational selection mechanism45,46, according to which different ligands would preferentially stabilize those states 
with optimal binding sites geometries. This scenario is also fully compatible with previous reports proposing a 
coupled folding/binding equilibrium for this domain28,30. Several pieces of experimental evidence support this 
idea: (a) the binding of the isolated PPPY motif elicits a high percentage (between 55 and 75%) of the binding 
enthalpy measured for longer and tighter binding ligands, suggesting that a good part of the conformational reor-
ganization is associated to the insertion of the core motif in the xP and xY conserved pockets, (b) the binding heat 
capacity of the p53bp2 ligand to NEDD4-WW3 is much larger than that of YAP-WW1 (ΔCp,app = −1.59 kJ K−1 
mol−1 and ΔCp,app = −0.90 kJ K−1 mol−1, respectively). This can be attributed to a higher level of conformational 
fluctuations in the free hNEDD4-WW3, in agreement with the stronger temperature dependence of the native 
state heat capacity observed by Differential Scanning Calorimetry for this domain44; and (c) large differences 
(up to 20 kJ·mol−1) in the enthalpic and entropic contributions to the binding affinity are observed between the 
different peptide ligands that cannot be accounted for by differences in the direct interactions at the binding 
interface. Also, the structure-based calculations reveal that binding to hNEDD4-WW3 elicits large enthalpic 
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contributions associated to conformational effects (Supplementary Table S5, see Methods for details) that vary 
strongly between the different ligands, with values for ΔHconf ranging between −30 and −65 kJ·mol−1. For other 
proteins studied, ΔHconf typically assumes common values for the different ligands with a small standard devia-
tion (between 0,4 and 5.9 kJ·mol−1)16. The large variability observed for the different hNEDD4-WW3 complexes 
(<ΔHconf >= −48 ± 14 kJ·mol−1) further sustains the idea that each ligand stabilizes enthalpically different con-
formations within the hNEDD4-WW3 conformational ensemble.
The fact that hNEDD4-WW3 complex structures sample the three binding modes identified within the type 
I WW structural database, further illustrates the conformational pliability of this domain that emerges as a key 
determinant of its functionality. Analysis of the available structural information reveals that the variability in 
ligand disposition and binding site organization seems to be a general feature for Type I WW domains, even 
within the subset of closely related WW domains from E3 ubiquitin ligases, and independently of the strength of 
the interaction. These results highlight the general plasticity of the WW domain binding sites and their ability to 
adapt to different ligand sequences, within the framework of a conformational selection mechanism that seems 
to be universal for WW domains. The finding that all high affinity WW complexes studied exquisitely select a 
specific I859 conformer, clearly illustrates this point, and is of interest for the definition of the optimal binding site 
geometry against which to tackle the design of high affinity ligands of potential biotechnological or therapeutic 
interest.
The results of the structural, thermodynamic and molecular dynamics study presented here provide valuable 
insight into the molecular basis of viral Late domain recognition by hNEDD4-WW3. We have shown that the 
determinants of binding affinity and specificity are in a good extent encoded within short Late domain sequences, 
even in the absence of additional elements from the viral proteins. These Late domains seem to have evolved to 
achieve a higher level of intrinsic specificity than ligands of cellular origin, for which contextual factors, such 
as the presence of other protein domains, the expression profile or subcellular localization seem to carry more 
weight. This paints a favorable scenario for drug design, since it indicates that a good level of binding affinity 
and specificity could be attained in these systems using relatively small molecules. Since the recognition of PPxY 
ligands by WW domains involves adaptable binding sites with variable geometries and entails strong enthalpy/
entropy compensation effects, which are major roadblocks in the design process, the incorporation of strate-
gies involving rational and non-rational and/or high-throughput approaches to the discovery process could be a 
potent complement to more traditional structure-based design approaches.
Methods
Protein expression and purification. The third WW domain of human NEDD4 (hNEDD4-WW3) com-
prising aminoacids 834–878 (UniProtKB/Swiss-Prot code P46934) was cloned as described elsewhere43. The first 
and the second WW domains of human YAP2 (YAP-WW1 and YAP-WW2), comprising aminoacids 165–209 
and 228–271 respectively (UniProtKB/Swiss-Prot code Q7Z574) were cloned by GENEART AG and subcloned 
into pETM-30 vector (Protein Expression and Purification Core Facility, EMBL, Heidelberg, Germany). All 
unlabelled protein samples were expressed as N-terminal GST-His-tagged proteins. For NMR experiments, 
the gene encoding the hNEDD4-WW3 domain was subcloned into a pETM-11 vector (Protein Expression and 
Purification Core Facility, EMBL, Heidelberg, Germany) and over-expressed in E. coli BL21/DE3 cells, fused to a 
His-tag at the N-terminus. The pETM30 and pETM11 plasmids introduce a TEV protease restriction site between 
the WW domain and the GST and His tags, respectively.
Uniformly labeled 15N hNEDD4-WW3 was expressed by growing cells in M9 medium containing 15NH4Cl as 
the only nitrogen source. For the production of the uniformly 13C- and 15N-labeled sample a minimal medium 
was used with [13C6]-glucose and 15NH4Cl as the only carbon and nitrogen sources, respectively. All protein sam-
ples were initially purified by nickel affinity chromatography, as described before43. GST and His-tag regions were 
removed by controlled hydrolysis with TEV protease. The isolated WW domains were further purified using a 
second step of nickel affinity chromatography followed by a gel filtration step on a HiLoad Superdex 75 column 
(GE healthcare Life Science). The purity and integrity of the purified proteins were checked by SDS-Page and 
Mass Spectrometry (Mass Spectrometry Service of the CIC at the University of Granada) and estimated to be 
over 99%. Immediately after the purification, all samples were frozen in liquid nitrogen in the purification buffer 
(300 mM NaCl 50 mM sodium phosphate buffer, pH 8.0) and stored at −80 °C.
peptide and protein samples. Protein concentrations were determined by absorption measurements at 
280 nm using molecular weights of 5568 Da, 5524 Da and 5410 Da and extinction coefficients of 11380 cm−1·M−1, 
12550 cm−1·M−1 and 13960 cm−1·M−1 determined as described by Gill & von Hippel47, for hNEDD4-WW3, 
YAP-WW1 and YAP-WW2, respectively. Synthetic lyophilized peptide ligands were purchased from SynBioSci 
Corporation with the exception of peptides Marburg and Rabies, which were bought from Peptide2.0 
Corporation. All the peptides were acetylated and amydated at their N and C termini, respectively. They were syn-
thesized on solid phase and their molecular mass was confirmed by mass spectrometry. Peptide purity (>95%) 
was assessed by analytical HPLC. For those ligands without tryptophan residues in their sequence (PPPY, p53bp2, 
HTLV1, Ebola and Marburg) peptide concentrations were determined by absorbance at 276 nm using an extinc-
tion coefficient of 1450 M−1 cm−1 per Tyrosine residue. Rabies concentration was measured by absorbance at 
280 nm using an extinction coefficient of 6990 M−1 cm−1.
Nuclear magnetic resonance (NMR) spectroscopy. hNEDD4-WW3 labelled samples were pre-
pared by concentrating the protein in 300 μL or 600 μL of buffer 20 mM phosphate pH 7 in H2O:D2O (19:1 
ratio by volume), containing 50 μM 2,2-dimethyl-2-silapentane-5-sulfonate sodium salt (DSS) as the internal 
reference for 1H chemical shifts. NMR experiments were performed at 288 K on a Bruker AV 700 spectrom-
eter or on a Bruker AV 600 spectrometer equipped with a cryoprobe. The protein:peptide ratios for HTLV1 
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or Ebola peptides were 1:3 and 1:10, respectively, which correspond to the last addition of ligand used in the 
NMR titrations. For sequence-specific polypeptide backbone and side-chain chemical shift assignments 1H-
1H TOCSY, 1H-1H NOESY, 1H-15N HSQC experiments were performed for both hNEDD4-WW3/HTLV1 and 
hNEDD4-WW3/Ebola complexes. Additional 13C-1H HSQC, HNCO, HNCACB, CBCA(CO)NH, (H)CC(CO)
NH, 15N-1H TOCSY-HSQC and 15N-edited NOESY-HSQC were performed for the assignment of the HTLV1 
complex48. Distance restraints were collected from the homonuclear and 15N-edited NOESY spectra recorded 
with a mixing time of 150 ms. Backbone 1H and 15N chemical shift assignments of the NEDD4-WW3 complexes 
were made using 15N-1H HSQC and 15N-edited NOESY-HSQC (80 ms mixing time) spectra recorded on uni-
formly 15N-labeled NEDD4-WW3 at 288 K. Chemical shifts were referenced to DSS used as an internal reference 
for 1H, and were calculated for 15N and 13C49. The average chemical shift perturbations resulting from complex 
formation were calculated using the equation:
Δ + ⋅ ΔN H( ) (5 )2 2
in which ΔΝ and ΔΗ are the chemical shift changes in the 15N and 1H resonances, respectively. The threshold for 
significant changes (0.03 ppm) was calculated using the spectral resolutions in the 1H and 15N acquisition dimen-
sions of the HSQC spectra as the values for ΔδH and ΔδN, respectively.
Structure calculations. Peak lists for the NOESY spectra were generated by interactive peak picking, and 
peak volumes were determined by the automatic integration function of XEASY package using the maximum 
option50. All data were processed using NMRPipe/NMRDraw51 and analyzed with CARA. Manually unambig-
uosly assigned peaks, dihedral angle restraints obtained from the backbone chemical shifts using TALOS52 and 
hydrogen-bond for antiparell strands were used during the calculation. The structures were calculated employ-
ing CNS53 with an in-house modified protocol of Aria1.254. The protocol calculates a set of 120 structures, with 
100,000 cooling steps according to Morales et al.27. The structural quality of the final 20 structures was evaluated 
with PROCHECK-NMR55, which also provided an average structure of the NMR ensemble. The statistics derived 
from the analysis are shown in Table 2. The resonance assignments have been deposited with BMRB entries 16574 
and 16575 and the refined models have been deposited with PDB entries 2KPZ and 2KQ0 for the HTLV1 complex 
and for the Ebola complex respectively.
The WW domain in the bound state was assigned using standard triple resonance experiments. The complete 
sequences of HTLV1 and Ebola ligands (Supplementary Table S1) bound to the WW3 domain were assigned 
using 2D 1H-1H TOCSY and 1H-1H NOESY experiments. All structure calculations were performed with 
N-term acetylated and C-term amidated peptides. Because only some ligand residues produced intermolecular 
NOE signals in the presence of the domain, shorter peptides sequences (2′-QIPPPYVEP-10′ for HTLV1 and 
2′-TAPPEYMEA-9′ for Ebola) were considered for the final calculation of the complex structures. The structural 
restrains for the secondary structure were obtained by the conformational relationships by residue based on the 
difference between the experimental and theoretical unfolded values of each nuclei49 and by the assignment of 
medium-distance and inter-stranded NOE signals.
fluorescence spectroscopy. The fluorescence emission spectra of the tryptophan residues in the WW 
domains were used to monitor any change in their environment upon peptide binding. Fluorescence was meas-
ured in an Eclipse spectrofluorimeter (Cary Varian). Samples were excited at 298 nm with a 5 nm slit and the flu-
orescence emission was detected between 300 nm and 500 nm through a 5 nm slit. Experiments were performed 
in 20 mM sodium phosphate pH 7.0, 25 °C at a protein concentration of 20 μM in a 1 cm path length cuvette. Each 
spectrum was corrected for ligand intrinsic fluorescence and normalized for protein concentration. Changes in 
spectral area due to intensity changes and shifts of the maximum of emission, were observed during the titration. 
The center of spectral mass was calculated as56:
∑ν ν= F F/i i N i N, ,
Where ν is the center of mass in wave numbers, Fi,N is the normalized fluorescence emitted at wave number νi. 
Assuming a one to one complex between the WW domains and the peptide, the Kd for the interaction of the dif-
ferent peptides was determined by fitting the changes in the CM versus ligand concentration, LT, to the equation:
ν ν ν ν= + − ⋅
+ + − + + −M L K M L K M L
M
( )
( ) ( ) 4
2M ML M
T T d T T d T T
T
2
Where νM is the center of mass for the free domain spectrum, νML is the center of mass for the spectrum of the 
complex (the last spectrum of the titration) and ΜT is the total concentration of the domain in the experiment.
Isothermal titration calorimetry (ITC). ITC experiments were performed using a high precision VP-ITC 
titration calorimetric system (Microcal Inc., Northampton, MA). The WW domains were extensively dialyzed 
against the titration buffer (20 mM sodium phosphate at pH 7.0). All solutions were filtered, properly degassed to 
avoid bubble formation, and equilibrated to 25 °C prior to each experiment. The protein solution (at 40–65 μM) 
in the calorimetric cell was titrated directly with the appropriate ligand (at 600–800 μM) dissolved in the dialysis 
buffer following a profile of injection volumes from 3 to 20 μl to better define the titration curve. The heat evolved 
after each peptide injection was obtained from the integral of the calorimetric signal. The heat produced by the 
binding reaction between the WW domains and the peptides was obtained as the difference between the heat 
of reaction and the corresponding heat of dilution, as obtained from independent titrations of the peptides into 
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the buffer. The resulting binding isotherms were analyzed by nonlinear least square fittings of the experimental 
data to a model corresponding to a single set of identical sites, as previously described32. For those ligands with 
binding affinities out of the range measurable directly by ITC57 (ligands PPPY, Ebola-ter and HTLV1-ter peptides 
with NEDD4-WW3 and YAP-WW1 domains) displacement experiments were performed58 using the p53bp2 
peptide as a competing ligand. In these cases, the protein solution (ca. 55 μM) with the peptide of interest at a 
molar ratio of saturation (ca. 0.8 mM) was placed in the calorimetric cell and titrated with the p53bp2 peptide (at 
2 mM) following a profile of injection volumes from 4 to 20 μl. The resulting binding isotherms, corrected for the 
dilution heats, were analyzed using the ORIGIN 7 software (Microcal Inc., Northampton, MA, USA) according 
to the Sigurskjold displacement model59. Typically, the variability in the experimental values were estimated to be 
about 1% in the number of binding sites, 5% in the binding enthalpy and 10% in the binding affinity.
Molecular dynamic simulations (MD). We used the atomic coordinates of the HTLV1/NEDD4-WW3 
and Ebola/NEDD4-WW3 determined in this work by NMR (see description above) as a starting point. The lig-
ands were acetylated and amidated in their extremes to avoid unrealistic electrostatic interactions using PyMOL 
Molecular Graphics System (Version 1.5.0.4 Schrödinger, LLC). Computation of the protonation state of ionisable 
groups was performed with pdb2pqr60. Counter-ions (to maintain system neutrality) and explicit water mole-
cules in a truncated octahedron box of TIP3P waters with 15 Å of cut-off were added using the LEAP module of 
AMBER 1261. Long range electrostatic interactions were treated by Particle-Mesh Ewald (PME)62. The standard 
ff12SB force filed was used to compute the interactions within protein63. The SHAKE algorithm64 was employed 
to constrain all bonds including hydrogen atoms. The systems were relaxed by three solvent minimization steps 
(5000-step steepest descent and 500-conjugate gradient steps) to remove structural clashes, followed by 20 ps 
heating up to 300 K and allowed to equilibrate during 100 ps following 5 steps progressively reducing restrictive 
restrains, until the absence of restrains in the last equilibration step. 40 ns of productive MD runs were performed 
in periodic boundary conditions in an isothermal isobaric ensemble at 1 atm, with 2-fs time integration steps. 
The trajectories were analyzed with the ptraj module of AMBERtools 12.061 and the free energies of binding were 
estimated with the MM-ISMSA approach65. A total of 10 clusters per trajectory were generated using the AMBER 
cpptraj command. Clusters with occurrences below 3% were considered as non-significantly populated.
Structure-based thermodynamic calculations. The analysis of the intermolecular interactions in the 
complex structures was performed using YASARA Structure66 with the standard parameters and definitions. 
Specifically, hydrogen bonds between potential donors and acceptors are considered if the hydrogen bond energy 
is better than 6,25 kJ·mol-1, which is 25% of the optimum value of 25 kJ·mol-1. Hydrogen bond energy is calcu-
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where DisH-A is the Hydrogen-Acceptor distance in Å; ScaleD-H-A is a scaling factor dependent on the angle 
formed by donor-hydrogen-acceptor; and ScaleH-A-X is a scaling factor dependent on the angle formed by 
hydrogen-acceptor and an atom, X, covalently bound to the acceptor.
The intrinsic binding enthalpy values were calculated according to Freire’s structural parameterization of the 
energetics67, as previously described16, using the lowest energy models of the Ebola (2KQ0), HTLV1 (2KPZ) and 
ENaC (1M30) NMR complexes and the x-ray structure of the ARRDC3 complex (4N7H). The intrinsic binding 
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Where ΔHint is the intrinsic binding enthalpy associated to the direct contacts between the protein domain and 
the ligand, ΔHconf correspond to the enthalpic contributions associated to changes in the conformational distribu-
tions of ligand and/or protein, ΔASAap and ΔASApol are the changes in accessible surface area upon binding of the 
ligand calculated according to the Lee and Richards algorithm as the average of 64 different ligand orientations 
and a probe radius of 1.4 Å.
Accession numbers. The structures solved in this work have been deposited in the Protein Data Bank with 
the PDB-ID 2KQ0 (Ebola/hNEDD4WW3) and 2KPZ (HTLV1/hNEDD4-WW3).
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